DIOSynVax


DIOSynVax combines cutting-edge science and advanced computational design to develop next-generation vaccines, protecting against today’s threats and tomorrow’s challenges.

Industries

biotechnology
information-technology-dbca

Nr. of Employees

small (1-50)

DIOSynVax

Cambridge, Cambridgeshire, United Kingdom, Europe


Products

Vaccine Antigen Payloads (VAPs)

Custom-designed antigens for vaccines that provide broad and deep protection against multiple virus strains and families, deployable in various vaccine vectors.

Antigen Design Platform

A platform that uses computational modeling and in vitro/in vivo validation to create antigens with broad and deep protection against viruses.

Self-Improving Algorithms

Machine learning algorithms that analyze virus data to predict mutations and improve vaccine candidate designs over time.


Services

Computational vaccine antigen design

Collaborative service applying computational design, bioinformatics and domain expertise to generate and prioritize vaccine antigen candidates.

Expertise Areas

  • Vaccine antigen design
  • Bioinformatics and sequence analysis
  • Vaccinology and immunology
  • Antigen payload development
  • Show More (2)

Key Technologies

  • Computational antigen design
  • Bioinformatics
  • Machine learning / data science
  • Sequence analysis
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.